US Stock Market "Will Crash," Warns Gingrich

18 December 1995

US House Speaker Newt Gingrich has asked the American Medical Association's leaders to pressure the White House and Congress to reach a compromise on Medicare, medicaid and the rest of the budget before Congress's holiday recess commences on December 22, or else see interest rates soar and the US stock market crash.

However, the feeling is that a budget deal may not be possible before the recess; one senior administration official now expects the issue to be "smoldering" when Congress reconvenes in january.

On December 6, President Bill Clinton used the pen with which President Johnson signed legislation creating Medicare 30 years ago to veto the Republican budget legislation pushed through Congress last month, claiming that the cuts for Medicare and Medicaid went too deep. He then presented his own budget proposals to Republicans the next day, when budget talks resumed, but his plan was described by House Budget Committee chairman John Kasich as "a tremendous disappointment."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight